Proactive Investors - Run By Investors For Investors

'This is the year Kromek turns a financial corner' - CEO Dr Arnab Basu

Dr Arnab Basu, chief executive of Kromek Group PLC (LON:KMK) runs Proactive through the firm's results for the year to the end of April 2017.

Dr Basu says they're now seeing a ''step change” across the business with revenues expected to grow 40% in the current year – in line with previous forecasts.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full KMK profile View Profile

Kromek Group PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use